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Identification details for selected compounds:
Compound 11: The compound was tentatively assigned as salicin-cysteine adduct, based on its molecular formula and MS/MS fragmentation pattern. Since cysteine adducts are no common microbial metabolites, we performed the following control experiment in order to find out how the observed adduct is formed: pure saligenin was mixed with cysteine (1 mg/ml each) in PBS buffer containing no human fecal suspension. In order to test whether the adduct is formed during analysis in the ESI source, one sample was measured directly after mixing saligenin and cysteine, however, no saligenin-cysteine adduct was detectable. Therefore, two further samples were prepared in the same way and incubated for 24 h, one at room temperature, and one at 37°C, mimicking the experimental conditions of HFS incubation. Indeed, after incubation, the adduct was detectable, with trace levels in the sample incubated at RT and high levels in the sample incubated at 37°C, indicating that the compound is an artefact which is spontaneously formed under the applied experimental conditions ( Figure S1 ). glucoside, as well as the chalcone glucoside isosalipurposide. Since these compounds share the same MS/MS fragmentation pattern, they cannot be discriminated on this basis. However, the chalcone isosalipurposide has a distinct UV spectrum ( max 370 nm vs.  max 280 nm for naringenin glycosides).
When we analyzed authentic naringenin-7-glucoside, the compound could be assigned to peak 47.
Low levels of 47 were detectable at t0 in WBE 10 mg/ml. In WBE 2 mg/ml, the levels of 47 were that low that it was not included in the processed LCMS data. However, inspection of the raw data showed that trace amounts of compound 47 were present in WBE 2 mg/ml at t0 as well. Concerning the two major naringenin hexoside peaks, we tentatively assigned compound 37 to (+)-naringenin-5-glucoside and compound 41 to its diastereomer (-)-naringenin-5-glucoside on the basis of their elution order described in earlier studies(5). Peak 52, eluting at 25.40 min, was tentatively assigned to the chalcone isosalipurposide due to its typical UV spectrum and due to the elution order that was in accordance with the one in the study by Kammerer 
